(Reuters) - The CDC estimated that risk of infection was at least seven
times greater among users of the Complete MoisturePlus solution
compared with those who did not, the company said.
"As patient safety is paramount to AMO, the company is
taking decisive action to stop shipments, recall product from
the marketplace, and encourage consumers to discontinue the use
of AMO Complete MoisturePlus until further information is
available," the company said in a statement.
Read more at Reuters.com Business News
times greater among users of the Complete MoisturePlus solution
compared with those who did not, the company said.
"As patient safety is paramount to AMO, the company is
taking decisive action to stop shipments, recall product from
the marketplace, and encourage consumers to discontinue the use
of AMO Complete MoisturePlus until further information is
available," the company said in a statement.
Read more at Reuters.com Business News
No comments:
Post a Comment